Last updated on March 2018

Trial to Assess the Pharmacokinetics Safety Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders


Brief description of study

A study to assess pharmacokinetics, safety and tolerability of brexpiprazole in children ages 6 to <13 years with CNS disorders.

Detailed Study Description

A US based nonrandomized, sequential cohort, crossover trial to assess pharmacokinetics, safety and tolerability of brexpiprazole in children ages 6 to <13 years with CNS disorders who are receiving antipsychotic treatment for their medical condition.

Clinical Study Identifier: NCT03292848

Contact Investigators or Research Sites near you

Start Over

Erin Foster

Woodland International Research Group
Little Rock, AR United States
  Connect »

Erin Foster

Woodland Research Northwest, LLC
Rogers, AR United States
  Connect »

Erin Foster

Alliance for Wellness dba Alliance for Research
Long Beach, CA United States
  Connect »

Erin Foster

New Hope Clinical Research
Charlotte, NC United States
  Connect »

Erin Foster

IPS Research Company
Oklahoma City, OK United States
  Connect »

Erin Foster

Cutting Edge Research Group
Oklahoma City, OK United States
  Connect »

Erin Foster

Clinical Trials of Texas, Inc.
San Antonio, TX United States
  Connect »

Erin Foster

Road Runner Research Ltd.
San Antonio, TX United States
  Connect »

Erin Foster

Aspen Clinical Research
Orem, UT United States
  Connect »